About Unlearn.ai
Unlearn.ai is a private company based in San Francisco, California. It has reported $114,999,947 raised in three offerings on Form D since April 2020. Its chief executive is Charles Fisher.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 25, 2024 | Feb 8, 2024 | $49,999,956fully sold | 9 | $5.5M | EquityRule 506(b) | Form D ↗ |
| Apr 5, 2022 | Apr 19, 2022 | $49,999,991fully sold | 14 | $3.5M | EquityRule 506(b) | Form D ↗ |
| Apr 3, 2020 | Apr 20, 2020amended Dec 15, 2020 | $15,000,000fully sold | 11 | $1.3M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $114,999,947 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Unlearn.ai's Form D filed Feb 8, 2024.
AS
Aaron Smith
Director
JM
John McGovern
Executive officer
DM
Dylan Morris
Director
Also a board member at Averna Therapeutics and a director at Gameto and ImmuneBridge.
ES
Eric Shiozaki
Director
AT
Ann Taylor
Director
Francisco Gimenez
Director
Also a director at BigHat Biosciences, Cambium Biomaterials and Flywheel Exchange.
AG
Andrew Gill
Executive officer
CF
Charles Fisher
President and Chief Executive Officer, director
EM
Ermira Murati
Director
Earlier filings also listed Jonathan Walsh (executive officer, last listed Apr 2022) and John Hamer (director, last listed Apr 2022).